An Interim Monitoring Visit (IMV) is a scheduled on-site evaluation conducted during the course of a clinical trial. It is performed by a clinical research associate or monitor to assess the progress of the study, ensure compliance with protocols, and verify the accuracy and completeness of data collected.
IMVs are crucial for maintaining the quality and integrity of clinical research. During these visits, monitors review source documents, case report forms, and other study-related materials to identify and address any issues or discrepancies that may have arisen since the previous visit.
Interim Monitoring Visits are essential for ensuring the ongoing quality and integrity of clinical trials. These visits allow for timely identification and correction of protocol deviations, data discrepancies, and other issues that could potentially compromise the validity of study results.
IMVs also play a crucial role in protecting the rights and safety of study participants. By regularly verifying adherence to ethical guidelines and regulatory requirements, these visits help maintain the highest standards of patient care and data management throughout the duration of a clinical trial.
Axcellant, a specialist global contract research organization (CRO), has been appointed by Switzerland-based Santersus AG to support the execution of…
Axcellant will participate in the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), taking place from 17…
3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…
Copyright @ 2026 Axcellant|Privacy Policy|Cookie Policy|